The Indian government recently has given the okay for phase I human clinical trials to be performed in India. This has led many to expect that the Contract Research Organization Industry, in India, will grow from being worth $200 million in 2007 to an estimated $600 million by 2010. There is one thing that could be preventing this estimate from coming true as remarked upon in this article. As Dr. S M Sapatnekar, dean and director of CREMA stated:
“The technology is constantly growing, and India is fast becoming a new hub for trials due to large patient population and strict compliance with the guidelines. However there is a serious dearth of researchers”
As an Ernst and Young report pointed out, 1000 students each year pass as researchers in India, however, by 2010 to keep up with demand, they will need 15,000 clinical researchers.
Search This Blog
Blog Archive
-
▼
2008
(97)
-
▼
October
(16)
- India possibility for Australia's CROs Needs
- CRO Stock Prices Going Down
- CROs Open New Opportunities for Employment
- Clinical Outsourcing Spend is Going Down
- Reducing Costs and Time of Cancer Trials
- Pharma Companies Are Outsourcing Less of Clinical ...
- Are companies budgeting less towards their outsour...
- Averion expands in Eastern Europe
- New report focusing on outsourcing in central Europe
- ethica Clinical Research expands to South America
- Clincal Trials in India
- Clinical Trials Today: ethica Heads to South America
- Bridge Laboratories to Support NIDA
- Changing Face of CRO's
- Update to China’s Growing Lead in Clinical Outsour...
- China is Ahead of India in Outsourced Trials
-
▼
October
(16)
No comments:
Post a Comment